Metastatic renal cell carcinoma patients of T4 stage who are in status of N1 stage or older than 76 years cannot benefit from cytoreductive nephrectomy

BACKGROUND: We aimed to identify which part of the patients with metastatic renal cell carcinoma (mRCC) is not suitable for cytoreductive nephrectomy (CN). METHODS: The data of mRCC patients was acquired from the Surveillance, Epidemiology, and End Results (SEER) database. Multivariate cox regressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhao, Wu, Hongliang, Yang, Tong, Wu, Yaohai, Yu, Nengwang, Xu, Zhonghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470438/
https://www.ncbi.nlm.nih.gov/pubmed/32883242
http://dx.doi.org/10.1186/s12885-020-07351-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470438/
https://www.ncbi.nlm.nih.gov/pubmed/32883242
http://dx.doi.org/10.1186/s12885-020-07351-w

Ejemplares similares